Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim: medical device reports filed with FDA

26,724 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

26,724
device reports naming the brand
0.1% of all MAUDE reports · about 3,866 a year
8,481
reports, 12 months to August 2026
6,955 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 26,724 reports that name the brand "BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim" (endosseous dental implant), received between August 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

8,481 reports arrived in the 12 months to August 2026, up 22% from 6,955 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (90.1%), loss of osseointegration (8.4%) and fracture (0.5%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

08941,787Sep 2021: 99Oct 2021: 145Nov 2021: 131Dec 2021: 1082022Jan 2022: 148Feb 2022: 120Mar 2022: 130Apr 2022: 159May 2022: 132Jun 2022: 138Jul 2022: 129Aug 2022: 154Sep 2022: 119Oct 2022: 198Nov 2022: 219Dec 2022: 1652023Jan 2023: 109Feb 2023: 150Mar 2023: 168Apr 2023: 236May 2023: 236Jun 2023: 318Jul 2023: 329Aug 2023: 369Sep 2023: 399Oct 2023: 365Nov 2023: 415Dec 2023: 4532024Jan 2024: 421Feb 2024: 464Mar 2024: 345Apr 2024: 563May 2024: 433Jun 2024: 542Jul 2024: 488Aug 2024: 426Sep 2024: 591Oct 2024: 353Nov 2024: 531Dec 2024: 5632025Jan 2025: 513Feb 2025: 349Mar 2025: 369Apr 2025: 364May 2025: 0Jun 2025: 1,787Jul 2025: 632Aug 2025: 903Sep 2025: 1,122Oct 2025: 553Nov 2025: 879Dec 2025: 8032026Jan 2026: 700Feb 2026: 719Mar 2026: 435Apr 2026: 544May 2026: 539Jun 2026: 846Jul 2026: 729Aug 2026: 612

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

04,1378,2742019: 33920192020: 69020202021: 1,21920212022: 1,81120222023: 3,54720232024: 5,72020242025: 8,27420252026: 5,1242026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%26,724
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report97.8%26,130
Voluntary report0%0
User facility report0%0
Distributor report2.2%594
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate24,08390.1%62.8%
Loss of osseointegration2,2558.4%22.4%
Fracturea broken bone1270.5%1.6%
Difficult to insertthe device was hard to insert560.2%0.4%
Separation failure130%0.1%
Difficult to removethe device was hard to remove40%0%
Unintended movement30%0%
Defective devicethe device was defective10%0%
Insufficient device problem information10%0.2%
Therapeutic or diagnostic output failure10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis4,86718.2%
Painpain, site not specified3,02111.3%
Inflammationinflammation1,4335.4%
Swelling/ edema1,2024.5%
Hemorrhage/blood loss/bleeding7252.7%
Tissue damage5782.2%
Fistula2691%
Abscessa collection of pus2631%
Numbnessnumbness1430.5%
Hyperresponsive to stimuli1160.4%
Hypersensitivity/allergic reaction960.4%
Failure of implant490.2%
Swellingswelling490.2%
Sinus perforation300.1%
Inadequate osseointegration280.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?4.1mm RC, SLA? 10mm, Ti, LoximProduct code DZEAll MAUDE reports
Reports26,7243,924,24126,136,888
Share of that pool—0.7%0.1%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer97.8%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%
NobelParallel CC RP 4.3x8.5mm23,8805,1500%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim reports

How many FDA reports name BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim?

26,724 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 8,481 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (90.1%), loss of osseointegration (8.4%), fracture (0.5%), difficult to insert (0.2%) and separation failure (0%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (97.8%) and distributor reports (2.2%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.